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Abstract
Compensatory hepatic regeneration after partial hepatec-
tomy (PH) is dependent upon the extent of resection. This
study analyzes the regulation of the AP-1 transcription fac-
tor c-Jun during hepatic regeneration. There is a progres-
sive increase in c-jun mRNA levels after sham operation,
one-third PH, and two-thirds PH. A concomitant increase
in AP-1 binding activity is also observed. The c-Jun protein
is a major constituent of the AP-1 complex in quiescent and
early regenerating liver. The activity of c-Jun nuclear kinase
(JNK), which phosphorylates the activation domain of the
c-Jun protein, is markedly stimulated after one-third PH.
JNK1 or an immunologically related kinase is a constituent
of this stimulated JNK activity after PH. When primary
cultures of adult rat hepatocytes are incubated with epider-
mal growth factor or transforming growth factor-a, AP-1
transcriptional activity is increased and the activation do-
main of the c-Jun protein is further potentiated. Phospho-
peptide mapping of the endogenous c-Jun protein in prolif-
erating cultured hepatocytes demonstrates phosphorylation
of the c-Jun activation domain. Combining the results of
these in vivo and culture studies, we conclude that the mini-
mal stimulation of one-third PH activates JNK, which phos-
phorylates the c-Jun activation domain in hepatocytes, re-
sulting in enhanced transcription of AP-1-dependent genes.
(J. Clin. Invest. 1995. 95:803-810.) Key words: hepatic re-
generation * transcription * c-Jun * signal transduction
kinase * proliferation
Introduction
Hepatocytes of normal adult liver divide infrequently. Immedi-
ately after partial hepatectomy (PH),' however, there is a se-
quential and regulated series of events as the quiescent hepato-
cytes progress in the cell cycle from Go to GI (1-4). These
include increased sodium ion influx (5) and induction of pro-
tooncogene expression. The early response genes that are in-
Address correspondence to Dr. D. A. Brenner, Department of Medicine,
CB#7080, University of North Carolina, Chapel Hill, NC 27599-7080.
Phone: 919-966-2511; FAX: 919-966-6842; e-mail: dab@med.unc.edu.
Receivedforpublication 1 July 1994 and in revisedform 25 October
1994.
1. Abbreviations used in this paper: EGF, epidermal growth factor;
ERK, extracellular signal-regulating kinase; JNK, c-Jun nuclear kinase;
PH, partial hepatectomy; SAPK, stress-activated protein kinase; TGFa,
transforming growth factor-a.
duced include c-fos, c-jun, Jun B, LRH-J, and c-myc ( 1-4, 6-
8). The induction of DNA synthesis and early response gene
and protein expression is proportional to the extent of PH
(9, 10).
The products of thejun andfos family of genes are compo-
nents of the transcription factor AP-1 (11, 12). The expression
of c-Jun is required for liver development, as demonstrated by
failure of hepatic development in a c-jun knock-out mouse ( 13 ).
The induction of c-jun mRNA after PH is independent of de
novo protein synthesis (1), and the c-jun gene is regulated by
autostimulation of its AP-1-binding site by the c-Jun pro-
tein (14).
The transcriptional activity of the c-Jun protein is regulated
by its phosphorylation status. Phosphorylation of the carboxy-
terminal c-Jun region near its DNA-binding site inhibits DNA
binding and therefore transcriptional activity (15, 16). How-
ever, phosphorylation of the c-Jun amino-terminal transcription
activation domain at Ser-63 and Ser-73 enhances transcriptional
activity (17-19). Phosphorylation of the amino-terminal do-
main is catalyzed by a c-Jun nuclear kinase, JNK, which has
been purified, and some of its constituents have been cloned
(20-22). Two-thirds PH in rats induces a marked stimulation
of c-jun mRNA levels as well as DNA synthesis (9, 23). We
have recently demonstrated that this activity is accompanied by
an early increase in JNK activity (24). These changes can be
simulated by treatment of quiescent hepatocyte cultures with
transforming growth factors (TGFa) (25).
We now demonstrate a proportional increase in JNK activity
in the liver after sham operation, one-third PH, and two-third
PH. There is also a proportional increase in c-jun mRNA levels
and AP-1 activity. Furthermore, in primary cultures of adult rat
hepatocytes, mitogens stimulate AP-1 transcriptional activity
and specifically stimulate the activity of the c-Jun activation
domain. Therefore, one of the earliest events after one-third PH
(this study) or two-thirds PH (24) is the induction of JNK
activity, which might be required for subsequent steps in hepato-
cyte proliferation.
Methods
Reagents and tissue culture media. All reagents are from Sigma Chemi-
cal Co. (St. Louis, MO) unless otherwise specified. All tissue culture
media were from Gibco BRL (Gaithersburg, MD). FBS was from Gem-
ini Biosciences (Calabassas, CA). Receptor-grade murine epidermal
growth factor (EGF) was from Sigma Chemical Co. Collagen type IV
was obtained from Collaborative Research (Bedford, MA). Percoll was
obtained from Pharmacia (Piscataway, NJ). Free fatty acids were from
NuChek (Elysian, MN). Polyclonal rabbit anti-c-Fos antiserum was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). c-Jun-
specific antiserum was provided by A. Kraft, University of Alabama.
Antiserum raised against recombinant JNKI was provided by M. Karin,
University of California, San Diego.
Plasmids. RSVcJun contains the coding sequence of human c-jun.
5XGal-Luc contains five repeats of the Gal4 DNA-binding site linked
to the luciferase reporter gene. Eukaryotic expression vector Gal4-cJun
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consists of the Gal4 DNA-binding domain linked to the c-Jun transcrip-
tional activation domain (amino acids 1-246). Gal4-cJun(AA) has
Ser-63 and Ser-73 mutated to Ala (20). Prokaryotic expression vectors
GST-cJun (amino acids 1-223 of c-Jun linked to the GST protein),
GST-cJun(AA) (with Ser-63 and Ser-73 mutated to alanines), and the
parental GST expression vector have been previously described (20).
The 2XTRE-Luc reporter (gift of K. Chien, University of California,
San Diego) contains four repeats of the consensus AP- I-binding site
linked to the minimal prolactin TATA box and the luciferase reporter
gene. Jun-Luc contains the human c-jun promoter from Jun-CAT (12,
14) linked to the luciferase reporter gene of P19-Luc.
Partial hepatectomy. The protocols for this study were approved by
the Department of Laboratory Animal Medicine at the University of
North Carolina, Chapel Hill, and at the University of California, San
Diego. Experiments were carried out in compliance with National Insti-
tutes of Health guidelines on the care and use of laboratory animals.
Male Sprague-Dawley rats (200-225 g; Harlan, Indianapolis, IN) were
anesthetized with 100 mg/kg ketamine, 2.5 mg/kg acepromazine, and
2 mg/kg lidocaine. In control animals (CO or T = 0), total hepatectomy
was performed immediately after anesthesia. For sham-operated ani-
mals, the liver was exposed by a median abdominal incision; for one-
third or two-thirds PH, the left liver lobe or the left and median lobes,
respectively, were ligated centrally. The unperfused liver tissue was
removed, and the incision was closed with sutures. The rats were allowed
to recover from anesthesia under observation. At various time points
after ligation (20 min, or 1, 2, 12, or 24 h), the remaining liver tissue
was removed and nuclear extracts or RNA was prepared.
RNA isolation and Northern blotting. Isolation of total hepatic RNA
was performed as previously described (26). RNA samples (25 mg)
were electrophoresed on 2.2 M formaldehyde-1% agarose gels, and
transferred to a nylon membrane (MSI, Westboro, MA). Equal loading
of RNA was confirmed by ethidium bromide staining of the gels. RNA
was ultraviolet cross-linked to the membrane, and blots were probed
with the following random-primed gene fragments: a 1-kb HindIII-PstI
fragment of RSVcJun (14), a 0.8-kb PstI fragment of murine c-fos
(27), a 1-kb HindIll fragment of rat serum albumin (28), and a 1.4-
kb HindIH-XbaI fragment of pCMV-Flag-JNKl (21) (provided by M.
Karin). Final wash stringency was 0.1 X SSC, 0.1% SDS at 600C.
Nuclear extracts and recombinant proteins. Nuclear extracts were
prepared as described (29) with the inclusion of protease and phospha-
tase inhibitors at all steps as follows: 0.1 mM PMSF, 2.0 jig/ml aproti-
nin, 2 ,ug/ml leupeptin, 2 Mg/ml bestatin, 0.7 pg/ml pepstatin, 20 mM
/3-glycerophosphate, 50 MM Na3VO4, 10 mM Na3MoO4, 10 mM NaF,
10 mM p-nitrophenylphosphate. Protein induction and purification in
the BL-21 strain of Escherichia coli (Novagen, Madison, WI) were
performed as described (30). Concentrations were determined by pro-
tein assay (Bio-Rad Laboratories, Hercules, CA), and nuclear extracts
were stored under liquid nitrogen.
Gel mobility shift assays. Determination of specific shifted com-
plexes was determined using a consensus AP-l site (5 '-TAAAGCATG-
AGTCAGGACACCTC-3') from the human collagenase gene as probe
(11) or the HNF- 1-binding site (5 '-TGTGGTTAATGATCTACA-
GTTA-3') from the rat serum albumin gene (11, 31). Probes were
labeled by reaction with T4 polynucleotide kinase (New England Bio-
labs, Beverly, MA) and [,y-32P]ATP. Binding reactions were performed
with 10 pg of nuclear extract for 20 min at room temperature, and
electrophoresis was as described previously (26) with a 1,000-fold ex-
cess of poly(dI/dC). Where indicated, 0.5 ,l of polyclonal rabbit antise-
rum specific for c-Jun, or 1 .l of anti-c-Fos polyclonal rabbit antisera
or preimmune rabbit serum, was included for the final 15 min of the
incubation at 37°C. Shifted complexes on 4% nondenaturing polyacryl-
amide gels were visualized by autoradiography.
Jun kinase assays. In vitro JNK assays were performed as described
(20) using purified recombinant GST-cJun, a mutated GST-cJun with
Ser-63 and Ser-73 mutated to ala (GST-cJUN(AA)), or GST protein
alone as substrate. Substrates (10 sg attached to glutathione-agarose
beads) were incubated with 50 Mg of nuclear extract, washed extensively
in buffer containing 0.5% Triton X-100, incubated with [y-32P]ATP
(4,000-10,000 Ci/mmol) and 40 pM ATP for 20 min at 30'C. These
were then washed and electrophoresed on 10% SDS-polyacrylamide
gels. The single prominent band on these gels represents phosphorylated
GST-cJun. The relative mass was confirmed by comparison with protein
molecular weight standards. For the JNK immune complex kinase
assays, 50 j.g of nuclear extract was incubated with antiserum raised
against JNK1, and immune complexes were collected with protein A-
plus/protein G-agarose (Oncogene Science, Uniondale, NY). After
washing extensively with RIPA, PAN + 0.5% NP-40, and PAN (32),
complexes were incubated in kinase buffer (as previously described)
containing GST-cJun, GST protein alone, or no substrate. Kinase reac-
tions and electrophoresis were performed as previously described.
Cell isolation and culture. Hepatocytes used in transfection and
labeling experiments were isolated by two methods. For primary hepato-
cytes plated on plastic dishes, cultures were prepared as described pre-
viously (33). For plating on collagen-coated plates, hepatocytes were
isolated from male Sprague-Dawley rats (220-225 g) by collagenase
perfusion (34). The cell suspension was purified and enriched for viable
hepatocytes by centrifugation over Percoll (35) leading to a purity of
98% hepatocytes and a viability of 93% as assessed by trypan blue
exclusion. The yield ranged from 1.5 x 108 to 2 x 108 cells per liver.
After washing the cells twice with DME, the hepatocytes were plated
on collagen type IV-coated 35-mm dishes (0.34 jsg of collagen per
cm') in 2 ml of MEM-S (MEM modified for suspension cultures)
containing 0.4 mM calcium, 10% dialyzed FBS, 2 mM glutamine, 100
jtg/ml gentamycin, 100 jzg/ml kanamycin, and 0.5 jig/ml fungizone
and cultured in a humidified atmosphere containing 5% CO2 at 37°C.
Transfections. Hepatocytes were prepared by collagenase perfusion
as previously described, and plated at a density of 1.2 x 106 cells per
35-mm plate in arginine-free DME plus 5% dialyzed FBS (for cells
plated on plastic). Other cells were plated on collagen. 1 h after plating,
the hepatocytes were washed twice with PBS, and the medium was
replaced with 1 ml of defined medium containing 0.4 mM calcium, 10
,ug/ml hydrocortisone, S pig/ml insulin, 10 ng/ml EGF, 2 mM glutamine,
plus antibiotics and antimycotics as previously described. 1 h later, cells
were transfected with 2.5 jsg of reporter plasmid and 0.5 ,ug of expres-
sion vector, as indicated, plus 10 jsg of Lipofectin reagent (Gibco BRL)
per plate. After 5 h, transfection mixtures were removed; cells were
washed once with PBS, and media were replaced with 2 ml of defined
media as previously described. After 4 d on plastic, or 1 d on type IV
collagen, EGF (10 ng/ml) or vehicle alone (PBS) was added to the
media. 5 and 24 h later, for cells on plastic and collagen, respectively,
extracts were prepared using enhanced luciferase assay reagents (Ana-
lytical Luminescence, San Diego, CA). Luciferase activity was mea-
sured on a Monolight 2010 (Analytical Luminescence, San Diego, CA)
for 20 s, and all results were normalized for extract protein concentration
determined with the Bio-Rad protein assay reagent.
Immunoprecipitation and phosphopeptide mapping. Primary cul-
tures of adult rat hepatocytes were prepared as previously described and
plated on plastic dishes at a density of 3.5 X 106 cells per 100-mm
plate. 24 h later, cells were transfected with 10 j.g of RSVcJun. 24 h
after removal of the transfection mixture, medium was changed to 2.5
ml of phosphate-free or methionine-free DME. After 30 min, 1 mCi of
[32P] orthophosphate or 150 pICi of Trans-35S-label (ICN Biochemicals,
Costa Mesa, CA) was added to the plates; incubation continued for an
additional 2.5 h. Where indicated, 10 ng/ml EGF (murine) was added
to the plate for the final 30 min before lysis of the cells. Cell lysis,
immunoprecipitation with c-Jun-specific antisera, and two-dimensional
phosphopeptide mapping were performed as previously described (36).
Results
Total cellular RNA was isolated for Northern blotting from
adult rat livers after sham operation, one-third PH, or two-thirds
PH. As previously described (2, 6), two-thirds PH results in a
transient induction of c-fos (Fig. 1 A) and a more prolonged
induction of c-jun mRNA (Fig. 1 B). Sham operation and one-
third PH result in no detectable c-fos mRNA. However, c-jun
mRNA levels are induced a maximum of 16-fold by two-thirds
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Figure 1. Hepatic mRNA levels after one-third and two-thirds PH. Autoradiograms
are shown of Northern blots of hepatic total RNA hybridized with probes forfos
(A), c-jun (B), and albumin (C). Each lane represents RNA from one animal. In
comparison with the 18S and 28S ribosomal RNAs, the molecular sizes of the mRNAs
are 2.2 kb for c-fos, 2.7 and 3.0 kb for c-jun, and 2.5 kb for albumin.
PH, 10-fold by one-third PH, and 6-fold by sham operation.
Albumin mRNA levels (Fig. 1 C) are slightly changed by the
surgical operations and serve as controls for mRNA integrity.
To assess the contribution of c-Jun protein to the AP-1
transcription complex in the liver, a series of mobility shift
assays were performed using an AP- I-binding site as the probe
and nuclear extracts prepared from sham or one-third PH livers
(Fig. 2). In the sham-operated animals, there is induction of
AP-1 binding activity, with a maximal increase of fivefold com-
pared with control (T = 0) animals (Fig. 2 A). In the one-
third PH animals, there is a greater stimulation of AP- binding
activity at time points after 20 min, with a 13-fold stimulation
achieved at 4 h (Fig. 2 A). The constituents of the AP-1 com-
plex were assessed using a specific antibody against c-Fos or
c-Jun. The anti-c-Fos antibody disrupted the AP-1 complex in
the one-third PH extracts at 20 min only, and not in control
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Figure 2. AP-1I binding activity of nuclear extracts is induced after one-
third PH and contains Jun and Fos proteins. (A) Time course of AP- 1
binding activity after one-third PH or sham operation. Extracts prepared
at the indicated times were incubated with a radiolabeled double-strand
DNA probe representing a consensus AP-1-binding site, incubated at
room temperature for 20 min, and fractionated on 4% nondenaturing
polyacrylamide gels. Shifted complexes were visualized by autoradiog-
raphy (top) or quantitated by phosphorimage analysis (bottom). (B)
Incubations with the indicated extracts were performed as previously
described, with the addition of Itid of normal rabbit serum (NRS),
irof c-Fos-specific antisera (c-fos), or with no addition (w/o Ab) for
an additional15-mmi incubation at37o (C) Incubations with probe
and the indicated extracts were performed as previously described, with
the addition of 0.5 Htlof normal rabbit serum (NRS), 0.5 1 of c-Jun-
specific antisera (c-jun), or with no addition (w/o Ab) for 15 mi at
370C.
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Figure 3. JNK activity is induced after PH. (A) Solid-phase in vitro
kinase assays were performed using ,ug of GST-cJun linked to agarose
as a substrate and 50 ,ug of the indicated hepatic nuclear extracts as the
kinase source. In lane 1, a non-fusion GST protein was incubated with
the I -h PH nuclear extract. In lane 2, a GST-cJun substrate mutated at
Ser-63 and Ser-73 (GST-cJun(AA)) was incubated with the 1-h PH
extract. Phosphorylated proteins were detected by autoradiography. (B)
Quantitation of A was by scintillation counting of excised bands.
(data not shown) or at subsequent time points (Fig. 2 B, and
data not shown). On the other hand, anti-c-Jun antiserum inhib-
ited the formation of the AP- 1 complex in control (T = 0)
nuclear extracts and at 1 h and 4 h after one-third PH. By 12
h after PH, the anti-c-Jun antiserum only partially disrupted
the AP-l complex (Fig. 2 C).
Previous studies have demonstrated that c-Jun is modified
by phosphorylation at several sites (15-19, 37). Therefore, we
assessed the ability of these hepatic nuclear extracts to phospho-
rylate the c-Jun activation domain in an in vitro kinase assay.
Using the same hepatic nuclear extracts as those discussed, one-
third PH results in a marked increase in the activity of a nuclear
kinase that phosphorylates the c-Jun activation domain (Fig. 3
A and B). The peak activity (greater than fivefold over sham
levels) is seen at 1 h after one-third PH. In the sham-operated
livers, JNK activity is minimally stimulated at 20 min and un-
stimulated at 1 h. As controls, GST protein and GST-cJun(AA)
(in which Ser-63 and Ser-73 are replaced by Ala) are used as
substrates in this assay (Fig. 3 A, lanes I and 2).
To characterize this JNK activity further, an immune com-
plex kinase assay was performed. Antisera raised against recom-
binant JNK1 protein (21) were used to precipitate a kinase
source from the same nuclear extracts. Extracts prepared from
livers 1 h and 4 h after one-third PH display increased kinase
activity specific for the c-Jun activation domain when compared
with the same time points in sham-operated or control animals
(Fig. 4 A). Thus JNK1 or an immunologically related kinase
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Figure 4. (A) JNKl activity is induced after one-third PH. Immune
complex kinase assays were performed using the indicated liver extracts
immunoprecipitated with antisera raised against JNKL. Complexes were
washed extensively and used as the kinase source in an in vitro kinase
assay with GST-cJun as the substrate (lanes 1-5, 7, and 8). Non-fusion
GST protein was used as control (lane 6). No phosphorylation of the
substrate was seen without the addition of antibody (lane 7) or extract
(lane 8). (B) Northern blot of total hepatic RNA from control (co),
sham-operated (sham), one-third PH, or two-thirds PH animals probed
with a JNKl cDNA. Migration of the 18S and 28S ribosomal bands is
indicated.
is induced following PH with kinetics similar to that seen in
the whole nuclear extract. A Northern blot ofRNA from control,
sham-operated, one-third PH, and two-thirds PH animals,
probed with a JNK1 cDNA (21), reveals no significant in-
creases in the mRNA levels of one prominent and one minor
transcript (Fig. 4 B). The slight decrease in JNK-1 mRNA
levels at 4 h after PH might contribute to the subsequent de-
crease in JNK-1 activity (Fig. 4 B).
To gain insight into the regulation of the AP- 1 transcription
factors in the proliferating hepatocytes, we performed studies
using primary cultures of adult rat hepatocytes. In the first set
of experiments we used primary cultures of adult rat hepatocytes
that are quiescent upon prolonged culture and in which prolifer-
ation is reinduced upon the addition of hepatic mitogens (25).
In this culture system, the hepatic mitogen TGFa stimulates c-
jun mRNA levels (25) and stimulates a luciferase reporter gene
driven by the c-jun promoter, which itself contains an AP- 1-
binding site (Jun-Luc; Fig. 5 A). To assess directly the role of
the c-Jun transactivation domain in the stimulation of AP-1
transcriptional activity in hepatocytes, we used a chimeric pro-
tein containing the c-Jun transactivation domain linked in frame
to the Gal4 DNA-binding domain. The potency of the transacti-
vation by this chimeric protein is assessed by the cotransfection
of a reporter gene containing five binding sites for the Gal4
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Figure 5. Jun activation in primary cultures of adult rat hepatocytes.
(A) Primary hepatocytes plated on plastic dishes were transfected with
a c-Jun promoter-luciferase reporter gene (Jun-Luc) and allowed to
become quiescent for 4 d. Cells were left unchanged, or subjected to
medium change with or without the addition of TGFa (10 ng/ml). 12
h later, extracts were assayed for luciferase activity and protein content.
(B) Primary hepatocytes were transfected with the 5XGal-Luc reporter
and Gal4-cJun, Gal4-cJun(AA), or the cognate empty expression vec-
tors. 4 d later, EGF (10 ng/ml) or PBS alone was added to the media,
and luciferase activity and protein concentrations were determined 5 h
later. Fold activation represents the activity of the indicated expression
vectors over the reporter activity in the presence of the empty expression
vector, normalized for protein content. (C) Primary hepatocytes were
plated on collagen type IV-coated plates and transfected with the indi-
cated reporter genes and expression vectors as previously described. 24
h after transfection, defined medium with EGF (10 ng/ml) or vehicle
(PBS) was added, and luciferase activity was determined 24 h later.
Results are expressed as fold activation normalized for protein content
as previously described. All graphs represents the results of two to four
experiments performed in duplicate.
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bating hepatocytes with the hepatic mitogen EGF stimulates the
expression of the reporter gene fourfold (Fig. 5 B). On the
other hand, after cotransfection of a chimeric protein containing
a mutated c-Jun transactivation domain in which Ser-63 and
Ser-73 are mutated to Ala, no stimulation by EGF was seen.
These experiments demonstrate that EGF enhances transcription
of c-Jun through its activation domain and requires these two
phosphorylation target sites.
Using a different culture system in which freshly isolated
hepatocytes are plated onto type IV collagen, the hepatocytes
are already proliferating (38). Transfections into these hepato-
cytes demonstrate that EGF further activates AP-1 -driven tran-
scription, as demonstrated by stimulation of the 2XTRE-luc
reporter gene, which contains four AP-1 -binding sites. Further-
more, the wild type but not mutant Gal4-cJun chimera exhibits
increased stimulation of the 5XGal-Luc reporter gene in the
presence of EGF (Fig. 5 C). Therefore, two separate methods
for culturing rat hepatocytes demonstrate increased activation
of AP-1 -dependent transcription after mitogen treatment and,
in particular, a role for the c-Jun activation domain in this
enhanced activity.
Finally, we assessed c-Jun phosphorylation in 2-d-old hepa-
tocyte cultures plated on plastic. Previous studies (39, 40) have
demonstrated that during this time the cells are transiting from
the lag to log phase of growth. The cultured hepatocytes were
incubated with [32p] orthophosphate and left untreated or treated
with EGF for the final 30 min before cell lysis. c-Jun protein was
then immunoprecipitated, gel purified, and trypsinized. Two-
dimensional phosphopeptide maps demonstrate that the c-Jun
is phosphorylated on its NH2-terminal activation domain at Ser-
63 and Ser-73, as indicated by the intense labeling of the X and
Y phosphopeptides (Fig. 6 A). Densitometry reveals that EGF
treatment (Fig. 6 B) increases the phosphorylation of these
amino-terminal peptides by 200%. Phosphorylation of peptides
adjacent to the DNA-binding domain (A, B, and C, Fig. 6)
increase to a lesser extent with EGF treatment, such that the
ratio of amino-terminal to carboxy-terminal peptide phosphory-
lation is increased by 40% after EGF treatment. Carboxy-termi-
nal phosphorylation is consistent with phosphorylation of at
least one of these sites by mitogen-activated protein kinases
(41, 42), which are activated by EGF in other cultured cells (22,
43). Therefore, c-Jun is phosphorylated on its amino-terminal
activation domain in proliferating cultured hepatocytes. We
have never observed significant phosphorylation of the activa-
tion domain in quiescent cells (43, and unpublished observa-
tions).
Discussion
This study is consistent with a model in which one-third PH
results in stimulation of JNK activity, phosphorylation of the
c-Jun activation domain, and increased transcription of genes
with AP-1 sites. After one-third PH (this study) or two-thirds
PH (24), one of the earliest biochemical changes we have
observed is the stimulation of JNK activity. The decrease in the
mobility of the hepatic c-Jun protein after PH is consistent with
the phosphorylation of its activation domain (data not shown).
When primary cultures of adult rat hepatocytes are treated with
mitogens, the phosphorylation of the c-Jun activation domain
is increased, resulting in enhanced transcriptional activity of
c-Jun and increased transcription of genes containing AP- 1-
binding sites.











Figure 6. c-Jun is phosphorylated on Ser-63 and Ser-73 in proliferating
hepatocytes. 100-mm tissue culture plates of primary hepatocytes were
transfected with a c-jun expression vector and, 24 h later, labeled with
1 mCi/ml [32P]orthophosphate or 150 ,Ci/ml Trans-35S-label. Cells
were lysed in RIPA buffer and immunoprecipitated with c-Jun-specific
antisera. After electrophoresis and transfer of proteins to nitrocellulose,
c-Jun was eluted, trypsinized, and subjected to two-dimensional phos-
phopeptide mapping. Electrophoresis was in the horizontal dimension
(left to right) and phosphochromatography in the vertical dimension.
(A) Map from proliferating hepatocytes. (B) Map from proliferating
hepatocytes treated with EGF for 30 min. Peptide spots labeled X and
Y contain Ser-73 and Ser-63, respectively. Spots labeled A, B, and
C correspond to peptides adjacent to the DNA-binding domain of
c-Jun (15).
sensitize the liver to regenerative stimuli. Sensitizing or priming
factors include protein starvation (44), thyroidectomy (45),
choline deficiency (46), alloxan-induced diabetes mellitus
(47), and one-third PH (9). Biochemical changes that underlie
this sensitization or priming event are unclear. However, mito-
gens such as EGF and TGFa, which stimulate initiation ofDNA
synthesis in quiescent hepatocyte cultures (25), induce several
changes that are possible candidates, including ion fluxes, Na+/
K+ ATPase, and induction of c-fos and c-jun (2, 5, 48). This
study demonstrates that an early event associated with sensitiza-
tion or priming is the activation of c-Jun amino-terminal kinase
activity (JNK), and, in particular, the activation of the kinase
JNK1 or an immunologically cross-reacting kinase. JNK activ-
ity is induced by 20 min and peaks at 1 h after one-third PH,
and JNKl-specific activity also peaks at 1 h. The activation of
JNK, which does not require de novo protein synthesis or gene
transcription, might be responsible for initiating and main-
taining the stimulation of the AP-1 transcription factor.
Our studies demonstrate a proportional increase in AP-1
activity between sham operation, one-third PH, and two-thirds
PH, as assessed by c-jun mRNA levels, AP-1 binding activity,
overall JNK activity, and JNK1 activity. For example, the maxi-
mal increase in JNK activity compared with control is 2.8-fold
following sham operation, 5.5-fold following one-third PH, and
11.9-fold following two-third PH. Previous studies in mice (2)
have also demonstrated a progressive stimulation of hepatic c-
fos mRNA levels from sham operation, 15% PH, 50% PH, and
70% PH. Differences between the present study and previous
studies, which showed either more (2) or less (9) effect of
sham operation on activation of AP-1 factors, might reflect
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differences in the sensitivity of the assays, the method of sham
operation, or the strain of rat. Our sham operation, consisting
of anesthesia, laparotomy, manipulation of the liver, surgical
closure of the abdomen, and anesthesia recovery, reflects the
stimulus of a normal surgical procedure. Regardless, sensitiza-
tion or priming does not appear to represent an all or nothing
event, but rather a continuum of increased stimulation of critical
biochemical events, including the activation of JNK.
The AP-1 transcription factors are a family of proteins that
form specific heterodimers or homodimers (49). Analysis of
AP-1 binding activity in the liver after PH demonstrates the
contribution of c-Fos to the complex only early during PH (20
min after one-third PH). On the other hand, c-Jun is a major
constituent of the AP- 1-binding complex in the quiescent liver
and through 4 h after PH. By 12 h after PH, c-Jun still contrib-
utes to the AP-1 complex, but other proteins are predominant.
These results are consistent with previous studies which report
that Jun-B/LRH-1 heterodimers increase late during hepatic
regeneration (8) and may be the major constituents at 12 h.
This study used primary cultures of adult rat hepatocytes to
study functional aspects of the AP-1 transcription factor that
were not amenable to in vivo experiments. Using reporter gene
transfections into two different hepatocyte culture systems
(plating on plastic or type IV collagen), we demonstrated that
the hepatic mitogens EGF and TGFa stimulate AP-1 transcrip-
tional activity. In particular, EGF stimulates the c-Jun activation
domain. This enhanced transcriptional activity correlates with
the phosphorylation of the c-Jun activation domain, in
agreement with previous studies in immortal cell lines. An indi-
rect assay for the JNK activity responsible for this phosphoryla-
tion is the ratio of the Gal4-Luc reporter gene activity elicited
by Gal4-cJun (stimulated by phosphorylation) compared with
Gal4-cJun(AA) (not sensitive to phosphorylation because of
mutations). Using this assay, we found that the plastic-plated
hepatocytes have lower basal JNK activity that is more EGF
inducible than the type IV collagen-plated hepatocytes. Thus,
together the in culture and in vivo results support a model in
which stimulation of hepatic JNK activity results in increased
c-Jun phosphorylation, enhanced AP-1 transcriptional activity,
and increase expression of AP- 1 -containing genes.
Previous studies have revealed multiple factors that activate
JNK activity in cultured cells (20-22, 37, 43, 50). Ultraviolet
light is the most potent inducer ofJNK activity (20, 21). Trans-
forming oncogenes, including oncogenic Ras and Raf, will stim-
ulate JNK activity ( 17-19, 36), and there is a direct correlation
between Ras transforming activity and c-Jun activation (36).
Finally, TNFa and, to lesser extent, EGF increase JNK activity
(22, 43). TNFa appears to stimulate JNK through a pathway
that is independent of Ras, Raf, or extracellular signal-regu-
lated kinase (ERK) activation (43). The initial mediator that
activates JNK after one-third PH is unknown. However, we
have recently demonstrated that a neutralizing antibody to
TNFa abolishes the activation ofJNK (24) and hepatic regener-
ation after two-thirds PH (24, 51 ). On the basis of the aforemen-
tioned data, TNFa is a potential candidate for the agonist that
stimulates in a paracrine manner the early stimulation of JNK
activity during hepatic regeneration.
In addition to multiple specific pathways leading to JNK
activity, recent evidence suggests that a family of closely related
kinases may be involved. JNK1, the first member of this family
to be cloned, is a 46-kD ultraviolet- and Ras-stimulated kinase
(20, 21) that mediates at least part of the TNFa-stimulated
JNK activity in fibroblasts (43). Several related proteins, called
stress-activated protein kinases (SAPKs), which share 90%
identity, have subsequently been cloned (22). One of these
(SAPKy) represents an alternately spliced form of JNKI (21,
22). All of these kinases are proline-directed serine/threonine
kinases and are related to ERKs 1 and 2. However, as they share
only - 40% homology with the ERKs, they are not functionally
interchangeable. The ERKs and JNKs (or SAPKs) participate
in different pathways and have different substrate specificities
(21, 22, 43, 52). Although proteins recognized by anti-JNKI
antiserum have increased kinase activity after PH, there is no
change in mRNA levels recognized by a JNKI cDNA probe.
This is reminiscent of the stimulation of ERK 1 and 2 activity
during proliferation, in which activity is induced despite un-
changed mRNA and protein levels (53).
The unique role of c-Jun in hepatic proliferation is reflected
in the failure of liver development in a c-Jun knock-out mouse
(13). Our study demonstrates that hepatocyte priming includes
the activation of JNK. The subsequent phosphorylation of the
c-Jun activation domain results in the activation of a preformed
transcription factor, which appears to be one of the earliest and
most sensitive changes preceding hepatic regeneration. There-
fore, JNK activity, which has previously been characterized in
immortal cell lines, is stimulated in vivo after PH.
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